Delivery Order SPE2DE24D0021-SPE2D625F0GQL
- Not listed
- This is a delivery order awarded by the Medical Supply Chain division of the Department of Defense to Fisher Scientific Company L.L.C. for the delivery of MAGMAX WASTEWATER NUC ACID KIT. The $2,456.00 fixed-price contract with economic price adjustment was awarded on November 26, 2024, with a completion date of December 9, 2024. The contract is not set aside for any small business designation. Fisher Scientific is a major supplier of scientific products, equipment, and services to federal...
- The U.S. Defense Department's Medical Supply Chain division awarded Fisher Scientific Company L.L.C. a delivery order valued at $3,080 for antigen COVID-19 testing kits on August 20, 2025, with an ultimate completion date of August 27, 2025. The contract is structured as fixed price with economic price adjustment and will be performed in Pittsburgh, Pennsylvania. This award was made through open competition with no set-aside designations, reflecting Fisher Scientific's established capability...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order contract valued at $1,173.24 by the Medical Supply Chain division of the Department of Defense on September 9, 2025, for MAGMAX viral/pathogen supplies. The contract is classified as a child award under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 30, 2025. No small business set-aside was utilized for this procurement, indicating the award was made...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,173.24 on August 6, 2025, for the supply of MAGMAX viral/pathogen products to support the Medical Supply Chain, a defense-related federal agency. This fixed-price delivery order with economic price adjustment features will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 27, 2025. The award was made through open competition with no set-aside designation, demonstrating Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order on July 22, 2025, for the procurement of 5X MAGMAX Pathogen RNA/DNA Kits with a ceiling value of $3,091.01. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of July 29, 2025. The contract will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was made through...
- Fisher Scientific Company L.L.C. has been awarded a $2,346.48 delivery order contract (Contract No. 4568797735) for MAGMAX Viral/Pathogen products by the Defense Department's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is scheduled for completion by August 5, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made on July 15, 2025, without any set-aside designation, reflecting Fisher Scientific's ability to compete...
- Fisher Scientific Company L.L.C. received a delivery order valued at $28,623.50 from the Department of Defense Medical Supply Chain for System PCR IV 1st Strain Superscript 50 Reaction kits, with an ultimate completion date of November 20, 2025. This fixed-price contract with economic price adjustment was awarded on November 5, 2025, with no set-aside designation, indicating open competition. The supplies will be delivered to Pittsburgh, Pennsylvania. This delivery order represents a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,171.36 for an RNA purification kit (KIT RNA PURF MAGMAX 40 MCG TL RNA 96) by the Department of Defense's Medical Supply Chain on January 15, 2026, with an ultimate completion date of January 21, 2026. This fixed-price delivery order with economic price adjustment carries no set-aside designation, indicating it was awarded through open competition. The work will be performed in Pittsburgh, Pennsylvania, where Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,173.24 on September 22, 2025, for the procurement of a kit containing nucleic acid purification reagents and a 96-well plate magnetic bead set. This fixed-price contract with economic price adjustment carries an ultimate completion date of October 7, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, reflecting open competition among qualified vendors. Funding...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order contract to Fisher Scientific Company L.L.C. on August 6, 2025, for direct polymerase chain reaction (PCR) reagents and kits, specifically MagMAX DNA products. This fixed-price delivery order with economic price adjustment carries a ceiling value of $1,952.64 and is scheduled for completion by August 18, 2025. The performance location is Pittsburgh, Pennsylvania. This award represents a child contract under a larger...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F0GQLDelivery Order
The U.S. Department of Defense Medical Supply Chain awarded Fisher Scientific Company L.L.C. a fixed-price delivery order valued at $1,319.08 for the MAGMAX Wastewater Nucleic Acid Kit on August 6, 2025. This child contract, which has no set-aside designation, is scheduled for completion by August 21, 2025, and will be performed in Pittsburgh, Pennsylvania. Fisher Scientific, a major supplier of laboratory supplies and scientific equipment to federal agencies, was selected through open competition to provide this specialized testing solution. The delivery order represents a procurement of nucleic acid extraction kits designed for wastewater analysis, supporting the Defense Department's Medical Supply Chain operations. As a registered vendor in SAM.gov since 2001, Fisher Scientific has established itself as a critical supplier of laboratory and medical equipment across numerous federal agencies, including the National Institutes of Health, Department of Veterans Affairs, and the Food and Drug Administration. The fixed-price structure with economic price adjustment provides cost certainty while allowing for inflation adjustments over the brief performance period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/6/25 |